000504 南华生物
已收盘 07-24 15:00:00
资讯
新帖
简况
每周股票复盘：南华生物（000504）涨逾20%登龙虎榜
证券之星 · 07-19
每周股票复盘：南华生物（000504）涨逾20%登龙虎榜
7月16日南华生物（000504）龙虎榜数据：机构净卖出1080.69万元（3日）
证券之星 · 07-16
7月16日南华生物（000504）龙虎榜数据：机构净卖出1080.69万元（3日）
异动快报：南华生物（000504）7月16日9点39分触及涨停板
证券之星 · 07-16
异动快报：南华生物（000504）7月16日9点39分触及涨停板
每周股票复盘：南华生物（000504）上半年净利扭亏为盈
证券之星 · 07-12
每周股票复盘：南华生物（000504）上半年净利扭亏为盈
股市必读：南华生物（000504）预计2026年1-6月营业收入2.5亿元至3亿元
证券之星 · 07-10
股市必读：南华生物（000504）预计2026年1-6月营业收入2.5亿元至3亿元
南华生物（000504）披露2026年半年度业绩预告，7月9日股价上涨3.2%
证券之星 · 07-09
南华生物（000504）披露2026年半年度业绩预告，7月9日股价上涨3.2%
南华生物：第十二届董事会第十次会议决议公告
经济观察网 · 07-09
南华生物：第十二届董事会第十次会议决议公告
南华生物：预计2026年1-6月每股收益盈利:0.0127元至0.0188元
证券之星 · 07-09
南华生物：预计2026年1-6月每股收益盈利:0.0127元至0.0188元
南华生物最新公告：预计上半年净利润420万元-620万元同比扭亏
证券之星 · 07-09
南华生物最新公告：预计上半年净利润420万元-620万元同比扭亏
异动快报：*ST生物（000504）6月4日10点16分触及跌停板
证券之星 · 06-04
异动快报：*ST生物（000504）6月4日10点16分触及跌停板
股市必读：*ST生物（000504）5月29日董秘有最新回复
证券之星 · 06-01
股市必读：*ST生物（000504）5月29日董秘有最新回复
*ST生物：截至2026年3月31日公司股东人数为10,803户
证券之星 · 05-29
*ST生物：截至2026年3月31日公司股东人数为10,803户
每周股票复盘：*ST生物（000504）申请撤销退市风险警示进展公布
证券之星 · 05-24
每周股票复盘：*ST生物（000504）申请撤销退市风险警示进展公布
*ST生物（000504）披露申请撤销退市风险警示进展公告，5月21日股价下跌1.18%
证券之星 · 05-21
*ST生物（000504）披露申请撤销退市风险警示进展公告，5月21日股价下跌1.18%
每周股票复盘：*ST生物（000504）一季度净利增600%
证券之星 · 05-02
每周股票复盘：*ST生物（000504）一季度净利增600%
*ST生物(000504)3月31日股东户数1.08万户，较上期减少9.06%
证券之星 · 04-29
*ST生物(000504)3月31日股东户数1.08万户，较上期减少9.06%
图解*ST生物年报：第四季度单季净利润同比增长306.35%
证券之星 · 04-29
图解*ST生物年报：第四季度单季净利润同比增长306.35%
异动快报：*ST生物（000504）4月24日14点1分触及涨停板
证券之星 · 04-24
异动快报：*ST生物（000504）4月24日14点1分触及涨停板
每周股票复盘：*ST生物（000504）面临终止上市风险
证券之星 · 03-22
每周股票复盘：*ST生物（000504）面临终止上市风险
*ST生物（000504）披露股票可能被终止上市的第四次风险提示公告，3月16日股价下跌2.04%
证券之星 · 03-16
*ST生物（000504）披露股票可能被终止上市的第四次风险提示公告，3月16日股价下跌2.04%
加载更多
公司概况
公司名称：
南华生物医药股份有限公司
所属行业：
科技推广和应用服务业
上市日期：
1992-12-08
主营业务：
南华生物医药股份有限公司的主营业务是人源细胞等检测、存储保管等服务；美妆净化器销售以及碳酸锂生产与销售、废钢加工与销售业务。公司的主要产品是节能产业销售及服务收入、EMC及工程建设、细胞储存及检测、生物医药相关产品销售。
发行价格：
1.00
{"stockData":{"symbol":"000504","market":"SZ","secType":"STK","nameCN":"南华生物","latestPrice":7.39,"timestamp":1784876616000,"preClose":7.86,"halted":0,"volume":8406700,"delay":0,"changeRate":-0.0598,"floatShares":329000000,"shares":330000000,"eps":0.1278,"marketStatus":"已收盘","change":-0.47,"latestTime":"07-24 15:00:00","open":7.7,"high":7.74,"low":7.38,"amount":63548300,"amplitude":0.0458,"askPrice":7.4,"askSize":159,"bidPrice":7.39,"bidSize":212,"shortable":0,"etf":0,"ttmEps":0.1278,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785115800000},"marketStatusCode":5,"adr":0,"adjPreClose":7.86,"symbolType":"stock","openAndCloseTimeList":[[1784856600000,1784863800000],[1784869200000,1784876400000]],"highLimit":8.65,"lowLimit":7.07,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":330023098,"isCdr":false,"pbRate":9.37,"roa":"--","peRate":57.824726,"roe":"4.09%","epsLYR":0.09,"committee":0.209302,"marketValue":2439000000,"turnoverRate":0.0255,"status":1,"floatMarketCap":2432000000},"requestUrl":"/m/hq/s/000504","defaultTab":"news","newsList":[{"id":"2652230112","title":"每周股票复盘：南华生物（000504）涨逾20%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652230112?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:45","pubTimestamp":1784400310,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，南华生物报收于8.55元，较上周的8.06元上涨6.08%。本周，南华生物7月16日盘中最高价报9.36元。交易信息汇总龙虎榜上榜沪深交易所2026年7月16日公布的交易公开信息显示，南华生物因连续三个交易日内涨幅偏离值累计达到20%登上龙虎榜。公司公告汇总南华生物股票交易异常波动的公告南华生物股票于2026年7月15日、7月16日连续两个交易日收盘价格涨幅累计偏离超过20%，构成异常波动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0282","BK0042","BK0046","000504","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651410260","title":"7月16日南华生物（000504）龙虎榜数据：机构净卖出1080.69万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2651410260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651410260?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:22","pubTimestamp":1784193747,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月16日公布的交易公开信息显示，南华生物因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月16日收盘，南华生物报收于9.36元，上涨9.99%，已连续涨停2天，换手率8.73%，成交量28.74万手，成交额2.65亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出1080.69万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600028157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0046","000504","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651497563","title":"异动快报：南华生物（000504）7月16日9点39分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2651497563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651497563?lang=zh_cn&edition=full","pubTime":"2026-07-16 09:41","pubTimestamp":1784166072,"startTime":"0","endTime":"0","summary":"证券之星7月16日盘中消息，9点39分南华生物（000504）触及涨停板。其所属行业医疗服务目前下跌。领涨股为昭衍新药。该股为污水处理，湖南国企改革，环保概念热股。7月15日的资金流向数据方面，主力资金净流入3376.1万元，占总成交额32.37%，游资资金净流出2291.27万元，占总成交额21.97%，散户资金净流出1084.83万元，占总成交额10.4%。近5日资金流向一览见下表：南华生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600008198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0086","BK0042","BK0046","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650672154","title":"每周股票复盘：南华生物（000504）上半年净利扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2650672154","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650672154?lang=zh_cn&edition=full","pubTime":"2026-07-12 02:25","pubTimestamp":1783794312,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，南华生物报收于8.06元，较上周的7.98元上涨1.0%。本周关注点来自业绩披露要点：南华生物预计2026年上半年归属净利润盈利420万元至620万元，实现扭亏为盈。公司公告汇总2026-037 南华生物2026年半年度业绩预告的公告南华生物预计2026年上半年营收25,000万元至30,000万元，同比增长384.57%至481.48%；归母净利润盈利420万元至620万元，扭亏为盈，上年同期亏损348.44万元；扣非后净利润盈利350万元至450万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071200000759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0042","BK0046","BK0282","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650017976","title":"股市必读：南华生物（000504）预计2026年1-6月营业收入2.5亿元至3亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650017976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650017976?lang=zh_cn&edition=full","pubTime":"2026-07-10 01:55","pubTimestamp":1783619712,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，南华生物报收于8.07元，上涨3.2%，换手率2.8%，成交量9.21万手，成交额7521.32万元。业绩披露要点业绩预告预计2026年1–6月每股收益盈利0.0127元至0.0188元；归属净利润盈利420万元至620万元；扣非后净利润盈利350万元至450万元；营业收入2.5亿元至3亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000001098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650200129","title":"南华生物（000504）披露2026年半年度业绩预告，7月9日股价上涨3.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650200129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650200129?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:32","pubTimestamp":1783607532,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，南华生物报收于8.07元，较前一交易日上涨3.2%，最新总市值为26.63亿元。近日，南华生物医药股份有限公司披露《2026年半年度业绩预告》。公告显示，公司预计2026年上半年实现营业收入25,000万元至30,000万元，同比增长384.57%至481.48%；归属于上市公司股东的净利润为盈利420万元至620万元，实现扭亏为盈。本次业绩预告未经会计师事务所预审计，具体财务数据以2026年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900042672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504","BK0046","BK0042","BK0282","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978664","title":"南华生物：第十二届董事会第十次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978664","media":"经济观察网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650978664?lang=zh_cn&edition=full","pubTime":"2026-07-09 22:23","pubTimestamp":1783606980,"startTime":"0","endTime":"0","summary":"登录新浪财经APP 搜索【信披】查看更多考评等级\n证券日报网讯 7月9日，南华生物发布公告称，公司第十二届董事会第十次会议审议通过《关于修订〈信息披露事务管理制度〉的议案》等多项议案。（编辑 姚尧）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-07-09/doc-inihfpqu4271311.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-09/doc-inihfpqu4271311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0282","000504","BK0042","BK0086","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650392153","title":"南华生物：预计2026年1-6月每股收益盈利:0.0127元至0.0188元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650392153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650392153?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:00","pubTimestamp":1783598444,"startTime":"0","endTime":"0","summary":"证券之星消息，南华生物发布业绩预告，预计2026年1-6月每股收益盈利:0.0127元至0.0188元。南华生物2026年一季报显示，一季度公司主营收入1.19亿元，同比上升431.32%；归母净利润1110.07万元，同比上升600.34%；扣非净利润1033.78万元，同比上升399.05%；负债率63.69%，投资收益49.87万元，财务费用231.91万元，毛利率20.46%。本文数据来源于《南华生物:2026-037南华生物2026年半年度业绩预告的公告》，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900038370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0282","BK0042","BK0086","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650692637","title":"南华生物最新公告：预计上半年净利润420万元-620万元同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2650692637","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650692637?lang=zh_cn&edition=full","pubTime":"2026-07-09 19:01","pubTimestamp":1783594908,"startTime":"0","endTime":"0","summary":"南华生物(000504.SZ)公告称，预计2026年上半年归母净利润为420万元-620万元，去年同期亏损348.44万元，同比扭亏为盈。报告期内，受益于碳酸锂及再生资源业务的开展，与上年同期相比，公司收入规模有较大幅度提升。注：公司Q2净利润预计亏损0.05亿-亏损0.07亿，Q1净利润0.11亿，据此计算，Q2净利润预计环比由盈转亏。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900035503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640013633","title":"异动快报：*ST生物（000504）6月4日10点16分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2640013633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640013633?lang=zh_cn&edition=full","pubTime":"2026-06-04 10:25","pubTimestamp":1780539950,"startTime":"0","endTime":"0","summary":"证券之星6月4日盘中消息，10点16分*ST生物（000504）触及跌停板。其所属行业医疗服务目前下跌。领涨股为百诚医药。该股为污水处理，环保，国企改革概念热股。6月3日的资金流向数据方面，主力资金净流出408.82万元，占总成交额12.9%，游资资金净流入347.32万元，占总成交额10.96%，散户资金净流入61.51万元，占总成交额1.94%。近5日资金流向一览见下表：*ST生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400010250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000504","BK0086","BK0042","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640855409","title":"股市必读：*ST生物（000504）5月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640855409","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640855409?lang=zh_cn&edition=full","pubTime":"2026-06-01 03:12","pubTimestamp":1780254734,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，*ST生物报收于9.46元，下跌2.07%，换手率1.11%，成交量3.65万手，成交额3480.04万元。董秘最新回复投资者： 董秘您好，关注到公司2025年收购娄底金弘新材料后，再生资源、锂电回收业务营收占比已大幅提升，远超原有生物医药板块，目前主营业务结构已发生明显变化。截至2026年3月31日公司股东人数为10,803户，相关数据请查阅公司定期报告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100001359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0046","000504","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639652620","title":"*ST生物：截至2026年3月31日公司股东人数为10,803户","url":"https://stock-news.laohu8.com/highlight/detail?id=2639652620","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639652620?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:53","pubTimestamp":1780059194,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST生物(000504)05月29日在投资者关系平台上答复投资者关心的问题。投资者提问：5月20日股东人数多少？*ST生物回复：尊敬的投资者，您好！截至2026年3月31日公司股东人数为10,803户，相关数据请查阅公司定期报告。感谢您的关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900043580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0086","BK0282","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637375946","title":"每周股票复盘：*ST生物（000504）申请撤销退市风险警示进展公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2637375946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637375946?lang=zh_cn&edition=full","pubTime":"2026-05-24 03:36","pubTimestamp":1779564973,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，*ST生物报收于9.49元，较上周的9.26元上涨2.48%。本周，*ST生物5月21日盘中最高价报9.5元。本周关注点公司公告汇总：*ST生物申请撤销退市风险警示，目前处于补充材料阶段。出席股东共111名，代表股份占公司总股本的42.2620%。南华生物关于申请撤销退市风险警示的进展公告指出，公司于2026年4月28日向深圳证券交易所提交撤销退市风险警示申请，截至2026年5月22日，该申请处于补充材料阶段，能否获批存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400001044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","BK0046","BK0086","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382260","title":"*ST生物（000504）披露申请撤销退市风险警示进展公告，5月21日股价下跌1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382260","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637382260?lang=zh_cn&edition=full","pubTime":"2026-05-21 18:32","pubTimestamp":1779359535,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，*ST生物报收于9.25元，较前一交易日下跌1.18%，最新总市值为30.53亿元。该股当日开盘9.38元，最高9.5元，最低9.2元，成交额达3664.1万元，换手率为1.19%。近日，*ST生物发布《关于申请撤销退市风险警示的进展公告》。公告显示，公司于2026年4月28日向深圳证券交易所提交了撤销退市风险警示的申请，相关公告已于2026年4月29日披露。截至公告披露日，该申请处于补充材料阶段，能否获批存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100036592.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0282","BK0046","BK0086","000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632092647","title":"每周股票复盘：*ST生物（000504）一季度净利增600%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632092647","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632092647?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:33","pubTimestamp":1777667589,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，*ST生物报收于9.18元，较上周的9.9元下跌7.27%。本周，*ST生物4月27日盘中最高价报10.28元。业绩披露要点：*ST生物2026年一季报显示，归母净利润1110.07万元，同比上升600.34%。公司公告汇总：*ST生物因2024年度多项财务指标不达标，股票已被实施退市风险警示。股本股东变化股东户数变动截至2026年3月31日，*ST生物股东户数为1.08万户，较2025年12月31日减少1076.0户，减幅为9.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","000504","BK0046","BK0282","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631964995","title":"*ST生物(000504)3月31日股东户数1.08万户，较上期减少9.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631964995","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631964995?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:46","pubTimestamp":1777455960,"startTime":"0","endTime":"0","summary":"证券之星消息，近日*ST生物披露，截至2026年3月31日公司股东户数为1.08万户，较12月31日减少1076.0户，减幅为9.06%。在医疗服务行业个股中，*ST生物股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.91万户。从股价来看，2025年12月31日至2026年3月31日，*ST生物区间涨幅为12.4%，在此期间股东户数减少1076.0户，减幅为9.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","000504","BK0282","BK0086","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631758043","title":"图解*ST生物年报：第四季度单季净利润同比增长306.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631758043","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631758043?lang=zh_cn&edition=full","pubTime":"2026-04-29 03:05","pubTimestamp":1777403116,"startTime":"0","endTime":"0","summary":"证券之星消息，*ST生物2025年年报显示，当年度公司主营收入4.16亿元，同比上升209.37%；归母净利润2882.87万元，同比上升245.26%；扣非净利润1069.03万元，同比上升136.62%；其中2025年第四季度，公司单季度主营收入3.33亿元，同比上升691.09%；单季度归母净利润2359.64万元，同比上升306.35%；单季度扣非净利润1029.26万元，同比上升164.61%；负债率63.95%，投资收益787.43万元，财务费用170.29万元，毛利率22.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900007780.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629897554","title":"异动快报：*ST生物（000504）4月24日14点1分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2629897554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629897554?lang=zh_cn&edition=full","pubTime":"2026-04-24 14:10","pubTimestamp":1777011046,"startTime":"0","endTime":"0","summary":"证券之星4月24日盘中消息，14点1分*ST生物触及涨停板。其所属行业医疗服务目前上涨。领涨股为普瑞眼科。该股为动力电池回收，干细胞，污水处理概念热股，当日动力电池回收概念上涨1.58%，干细胞概念上涨0.78%，污水处理概念上涨0.16%。4月23日的资金流向数据方面，主力资金净流出697.67万元，占总成交额25.56%，游资资金净流入355.04万元，占总成交额13.01%，散户资金净流入342.63万元，占总成交额12.55%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400041019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0282","000504","BK0042","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621796707","title":"每周股票复盘：*ST生物（000504）面临终止上市风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796707?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:26","pubTimestamp":1774117573,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，*ST生物报收于9.64元，较上周的10.31元下跌6.5%。本周，*ST生物3月17日盘中最高价报10.5元。*ST生物当前最新总市值31.81亿元，在医疗服务板块市值排名46/51，在两市A股市值排名4444/5190。本周关注点公司公告汇总：南华生物因2024年度多项财务指标为负且营收低于3亿元，已被实施退市风险警示，若2025年度继续触及相关规定，股票将被终止上市。公司已多次发布风险提示公告，提醒投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","000504","BK0042","BK0282"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619454456","title":"*ST生物（000504）披露股票可能被终止上市的第四次风险提示公告，3月16日股价下跌2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619454456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619454456?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:26","pubTimestamp":1773653163,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，*ST生物报收于10.1元，较前一交易日下跌2.04%，最新总市值为33.33亿元。该股当日开盘10.18元，最高10.37元，最低10.05元，成交额达4701.81万元，换手率为1.41%。近日，*ST生物发布《股票可能被终止上市的第四次风险提示公告》。公司已多次发布风险提示公告，提醒投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600024142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","000504","BK0282","BK0086"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785096455593,"stockEarnings":[{"period":"1week","weight":-0.1357},{"period":"1month","weight":-0.0634},{"period":"3month","weight":-0.2535},{"period":"6month","weight":-0.165},{"period":"1year","weight":-0.2955},{"period":"ytd","weight":-0.1743}],"compareEarnings":[{"period":"1week","weight":0.0133},{"period":"1month","weight":-0.0722},{"period":"3month","weight":-0.0651},{"period":"6month","weight":-0.0778},{"period":"1year","weight":0.0578},{"period":"ytd","weight":-0.039}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南华生物医药股份有限公司","boardCode":"AI0075","boardName":"科技推广和应用服务业","stockholders":"10803人(较上一季度减少9.06%)","perCapita":"30465股","listingDate":"1992-12-08","address":"湖南省长沙市岳麓区高新区岳麓西大道1698号麓谷科技创新创业园B1栋3楼","registeredCapital":"33002万元","survey":" 南华生物医药股份有限公司的主营业务是人源细胞等检测、存储保管等服务；美妆净化器销售以及碳酸锂生产与销售、废钢加工与销售业务。公司的主要产品是节能产业销售及服务收入、EMC及工程建设、细胞储存及检测、生物医药相关产品销售。","listedPrice":1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南华生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南华生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南华生物,000504,南华生物股票,南华生物股票老虎,南华生物股票老虎国际,南华生物行情,南华生物股票行情,南华生物股价,南华生物股市,南华生物股票价格,南华生物股票交易,南华生物股票购买,南华生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南华生物(000504)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南华生物(000504)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}